Pegloticase, a polyethylene glycol conjugate of uricase for the potential intravenous treatment of gout |
| |
| Authors: | Biggers Kristen Scheinfeld Noah |
| |
| Affiliation: | West Virginia University School of Medicine, Robert C Byrd Health Sciences Center, Morgantown, WV 26506-9100, USA. |
| |
| Abstract: | Savient Pharmaceuticals Inc (formerly Bio-Technology General Corp), under license from Duke University, is developing pegloticase, PEG conjugates of uricase (urate oxidase), for the potential treatment of gout. The in-life portion of the phase III trials have been completed. |
| |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ |
|
